BridgeBio Pharma, Inc. 2.5% 15-MAR-2027BridgeBio Pharma, Inc. 2.5% 15-MAR-2027BridgeBio Pharma, Inc. 2.5% 15-MAR-2027

BridgeBio Pharma, Inc. 2.5% 15-MAR-2027

No trades
See on Supercharts

Key terms


Outstanding amount
‪550.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
3.37%
Maturity date
Mar 15, 2027
Term to maturity
2 years

About BridgeBio Pharma, Inc. 2.5% 15-MAR-2027


Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Mar 16, 2021
FIGI
BBG00S6RF7K8
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.